US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist

17.493
+0.293+1.70%

Trading Nov 26 14:00 ET

256.20MMarket Cap-2634P/E (TTM)

Anika Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-22.65%5.02M

87.11%-1.07M

96.52%-126K

-140.55%-1.79M

656.34%3.64M

139.39%6.49M

-368.56%-8.29M

-93.58%-3.62M

-47.49%4.41M

-89.24%481K

Net income from continuing operations

-354.96%-29.92M

96.79%-88K

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

Operating gains losses

----

--1.92M

--65K

----

Depreciation and amortization

-38.23%2.19M

-42.03%2.06M

-41.90%2.06M

-1.86%14.22M

-2.51%3.57M

1.34%3.54M

-4.29%3.55M

-1.82%3.55M

1.19%14.49M

-1.72%3.67M

Deferred tax

84.76%-184K

101.88%17K

108.13%193K

-20.06%-6.33M

-3.60%-1.84M

17.95%-1.21M

48.25%-904K

-769.23%-2.37M

-198.41%-5.27M

36.10%-1.78M

Other non cash items

7.13%586K

-24.63%410K

4.24%565K

20.59%2.23M

13.26%598K

4.19%547K

38.07%544K

34.49%542K

114.30%1.85M

-63.26%528K

Change In working capital

-56.63%1.49M

40.84%-8.04M

-750.93%-4.18M

-2.55%-12.12M

-5.88%-2.61M

224.14%3.44M

-1,676.99%-13.59M

111.03%642K

19.68%-11.82M

-372.79%-2.47M

-Change in receivables

149.56%4.78M

71.41%-1.77M

-10.67%3.62M

76.82%-1.31M

-70.63%-1.1M

201.86%1.92M

-77.08%-6.17M

959.27%4.06M

9.43%-5.63M

-130.74%-647K

-Change in inventory

-42.66%-3M

-52.87%-4.72M

-33.53%-4.09M

-65.81%-11.4M

-6.77%-3.14M

12.00%-2.11M

-228.97%-3.09M

-408.80%-3.06M

-3.84%-6.87M

-690.36%-2.94M

-Change in prepaid assets

-458.06%-222K

4.60%1.27M

-18.61%-548K

170.71%560K

23.21%-258K

-87.40%62K

405.39%1.22M

61.14%-462K

-155.62%-792K

23.64%-336K

-Change in payables and accrued expense

-117.18%-734K

63.79%-1.68M

-5,543.75%-2.71M

7.56%1.64M

133.64%2.04M

178.67%4.27M

-283.91%-4.63M

98.59%-48K

-36.85%1.52M

10,825.00%874K

-Change in other current liabilities

-7.59%-567K

25.33%-392K

-4.40%-546K

-44.71%-2.15M

-33.18%-574K

-81.72%-527K

-39.26%-525K

-35.14%-523K

66.30%-1.49M

-13.72%-431K

-Change in other working capital

800.00%1.24M

-92.17%-761K

-86.78%90K

-63.12%530K

-58.38%422K

24.36%-177K

-130.96%-396K

209.49%681K

209.61%1.44M

214.19%1.01M

Cash from discontinued investing activities

Operating cash flow

-22.65%5.02M

87.11%-1.07M

96.52%-126K

-140.55%-1.79M

656.34%3.64M

139.39%6.49M

-368.56%-8.29M

-93.58%-3.62M

-47.49%4.41M

-89.24%481K

Investing cash flow

Cash flow from continuing investing activities

-145.07%-1.82M

-133.56%-3.4M

-30.17%-1.81M

27.50%-5.43M

27.24%-1.84M

56.18%-741K

24.90%-1.46M

-4.75%-1.39M

-140.09%-7.49M

-103.95%-2.53M

Net PPE purchase and sale

-64.10%-1.22M

-133.56%-3.4M

-30.17%-1.81M

27.50%-5.43M

27.24%-1.84M

56.18%-741K

24.90%-1.46M

-4.75%-1.39M

-45.56%-7.49M

-124.40%-2.53M

Net business purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

----

--0

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-145.07%-1.82M

-133.56%-3.4M

-30.17%-1.81M

27.50%-5.43M

27.24%-1.84M

56.18%-741K

24.90%-1.46M

-4.75%-1.39M

-140.09%-7.49M

-103.95%-2.53M

Financing cash flow

Cash flow from continuing financing activities

-3,528.18%-3.99M

77.52%-1.11M

-40.92%-2.27M

-30.34%-6.32M

-48.73%342K

97.61%-110K

-10,645.65%-4.94M

-87.12%-1.61M

28.43%-4.85M

1,011.67%667K

Net issuance payments of debt

----

--0

----

-41.29%-284K

--0

Net common stock issuance

---3.97M

----

---5M

--0

----

--0

Proceeds from stock option exercised by employees

--0

-4.53%464K

228.57%23K

21.59%828K

-49.70%335K

--0

--486K

-53.33%7K

-39.63%681K

484.21%666K

Net other financing activities

80.00%-22K

52.21%-205K

-41.73%-2.3M

59.00%-2.15M

600.00%7K

97.49%-110K

-1,687.50%-429K

-91.49%-1.62M

31.88%-5.25M

101.59%1K

Cash from discontinued financing activities

Financing cash flow

-3,528.18%-3.99M

77.52%-1.11M

-40.92%-2.27M

-30.34%-6.32M

-48.73%342K

97.61%-110K

-10,645.65%-4.94M

-87.12%-1.61M

28.43%-4.85M

1,011.67%667K

Net cash flow

Beginning cash position

-3.46%62.82M

-13.93%68.63M

-15.59%72.87M

-8.54%86.33M

-19.51%70.65M

-28.80%65.07M

-11.72%79.74M

-8.54%86.33M

-1.49%94.39M

-3.52%87.78M

Current changes in cash

-114.04%-791K

62.00%-5.58M

36.45%-4.21M

-70.75%-13.54M

254.96%2.14M

256.80%5.63M

-1,433.30%-14.69M

-63.17%-6.62M

-428.60%-7.93M

-141.95%-1.38M

Effect of exchange rate changes

724.07%337K

-929.63%-224K

-203.33%-31K

160.77%79K

210.14%76K

-145.45%-54K

177.14%27K

850.00%30K

-288.41%-130K

-158.47%-69K

End cash Position

-11.72%62.37M

-3.46%62.82M

-13.93%68.63M

-15.59%72.87M

-19.51%70.65M

-28.80%65.07M

-11.72%79.74M

-8.54%86.33M

Free cash flow

-44.29%3.2M

54.13%-4.47M

61.37%-1.93M

-134.48%-7.22M

187.79%1.8M

464.24%5.74M

-949.30%-9.75M

-56.71%-5.01M

-194.56%-3.08M

-161.23%-2.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-22.65%5.02M	87.11%-1.07M	96.52%-126K	-140.55%-1.79M	656.34%3.64M	139.39%6.49M	-368.56%-8.29M	-93.58%-3.62M	-47.49%4.41M	-89.24%481K
Net income from continuing operations	-354.96%-29.92M	96.79%-88K	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M
Operating gains losses	----	----	----	--1.92M	--65K	----	----	----	----	----
Depreciation and amortization	-38.23%2.19M	-42.03%2.06M	-41.90%2.06M	-1.86%14.22M	-2.51%3.57M	1.34%3.54M	-4.29%3.55M	-1.82%3.55M	1.19%14.49M	-1.72%3.67M
Deferred tax	84.76%-184K	101.88%17K	108.13%193K	-20.06%-6.33M	-3.60%-1.84M	17.95%-1.21M	48.25%-904K	-769.23%-2.37M	-198.41%-5.27M	36.10%-1.78M
Other non cash items	7.13%586K	-24.63%410K	4.24%565K	20.59%2.23M	13.26%598K	4.19%547K	38.07%544K	34.49%542K	114.30%1.85M	-63.26%528K
Change In working capital	-56.63%1.49M	40.84%-8.04M	-750.93%-4.18M	-2.55%-12.12M	-5.88%-2.61M	224.14%3.44M	-1,676.99%-13.59M	111.03%642K	19.68%-11.82M	-372.79%-2.47M
-Change in receivables	149.56%4.78M	71.41%-1.77M	-10.67%3.62M	76.82%-1.31M	-70.63%-1.1M	201.86%1.92M	-77.08%-6.17M	959.27%4.06M	9.43%-5.63M	-130.74%-647K
-Change in inventory	-42.66%-3M	-52.87%-4.72M	-33.53%-4.09M	-65.81%-11.4M	-6.77%-3.14M	12.00%-2.11M	-228.97%-3.09M	-408.80%-3.06M	-3.84%-6.87M	-690.36%-2.94M
-Change in prepaid assets	-458.06%-222K	4.60%1.27M	-18.61%-548K	170.71%560K	23.21%-258K	-87.40%62K	405.39%1.22M	61.14%-462K	-155.62%-792K	23.64%-336K
-Change in payables and accrued expense	-117.18%-734K	63.79%-1.68M	-5,543.75%-2.71M	7.56%1.64M	133.64%2.04M	178.67%4.27M	-283.91%-4.63M	98.59%-48K	-36.85%1.52M	10,825.00%874K
-Change in other current liabilities	-7.59%-567K	25.33%-392K	-4.40%-546K	-44.71%-2.15M	-33.18%-574K	-81.72%-527K	-39.26%-525K	-35.14%-523K	66.30%-1.49M	-13.72%-431K
-Change in other working capital	800.00%1.24M	-92.17%-761K	-86.78%90K	-63.12%530K	-58.38%422K	24.36%-177K	-130.96%-396K	209.49%681K	209.61%1.44M	214.19%1.01M
Cash from discontinued investing activities
Operating cash flow	-22.65%5.02M	87.11%-1.07M	96.52%-126K	-140.55%-1.79M	656.34%3.64M	139.39%6.49M	-368.56%-8.29M	-93.58%-3.62M	-47.49%4.41M	-89.24%481K
Investing cash flow
Cash flow from continuing investing activities	-145.07%-1.82M	-133.56%-3.4M	-30.17%-1.81M	27.50%-5.43M	27.24%-1.84M	56.18%-741K	24.90%-1.46M	-4.75%-1.39M	-140.09%-7.49M	-103.95%-2.53M
Net PPE purchase and sale	-64.10%-1.22M	-133.56%-3.4M	-30.17%-1.81M	27.50%-5.43M	27.24%-1.84M	56.18%-741K	24.90%-1.46M	-4.75%-1.39M	-45.56%-7.49M	-124.40%-2.53M
Net business purchase and sale	----	----	----	--0	----	----	----	----	--0	----
Net investment purchase and sale	----	----	----	--0	----	----	----	----	--0	----
Cash from discontinued investing activities
Investing cash flow	-145.07%-1.82M	-133.56%-3.4M	-30.17%-1.81M	27.50%-5.43M	27.24%-1.84M	56.18%-741K	24.90%-1.46M	-4.75%-1.39M	-140.09%-7.49M	-103.95%-2.53M
Financing cash flow
Cash flow from continuing financing activities	-3,528.18%-3.99M	77.52%-1.11M	-40.92%-2.27M	-30.34%-6.32M	-48.73%342K	97.61%-110K	-10,645.65%-4.94M	-87.12%-1.61M	28.43%-4.85M	1,011.67%667K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	-41.29%-284K	--0
Net common stock issuance	---3.97M	----	----	---5M	--0	--0	----	----	--0	--0
Proceeds from stock option exercised by employees	--0	-4.53%464K	228.57%23K	21.59%828K	-49.70%335K	--0	--486K	-53.33%7K	-39.63%681K	484.21%666K
Net other financing activities	80.00%-22K	52.21%-205K	-41.73%-2.3M	59.00%-2.15M	600.00%7K	97.49%-110K	-1,687.50%-429K	-91.49%-1.62M	31.88%-5.25M	101.59%1K
Cash from discontinued financing activities
Financing cash flow	-3,528.18%-3.99M	77.52%-1.11M	-40.92%-2.27M	-30.34%-6.32M	-48.73%342K	97.61%-110K	-10,645.65%-4.94M	-87.12%-1.61M	28.43%-4.85M	1,011.67%667K
Net cash flow
Beginning cash position	-3.46%62.82M	-13.93%68.63M	-15.59%72.87M	-8.54%86.33M	-19.51%70.65M	-28.80%65.07M	-11.72%79.74M	-8.54%86.33M	-1.49%94.39M	-3.52%87.78M
Current changes in cash	-114.04%-791K	62.00%-5.58M	36.45%-4.21M	-70.75%-13.54M	254.96%2.14M	256.80%5.63M	-1,433.30%-14.69M	-63.17%-6.62M	-428.60%-7.93M	-141.95%-1.38M
Effect of exchange rate changes	724.07%337K	-929.63%-224K	-203.33%-31K	160.77%79K	210.14%76K	-145.45%-54K	177.14%27K	850.00%30K	-288.41%-130K	-158.47%-69K
End cash Position	-11.72%62.37M	-3.46%62.82M	-13.93%68.63M	-15.59%72.87M	-15.59%72.87M	-19.51%70.65M	-28.80%65.07M	-11.72%79.74M	-8.54%86.33M	-8.54%86.33M
Free cash flow	-44.29%3.2M	54.13%-4.47M	61.37%-1.93M	-134.48%-7.22M	187.79%1.8M	464.24%5.74M	-949.30%-9.75M	-56.71%-5.01M	-194.56%-3.08M	-161.23%-2.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data